Lipocine Inc.

LPCNNASDAQHealthcare● Active

$2.04

$-0.01(-0.49%)

Market Cap$11839154

P/E Ratio—

52W High$12.37

52W Low$1.81

Avg Volume395K

Open$2.09

Beta0.46

Overview

Lipocine Inc. (LPCN) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · LPCN · as of Mar 10, 2026

Latest filing snapshot

-2-12.50%vs prior year

Lipocine Inc. (LPCN) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

Change (1Y)

-2

Growth % (1Y)

-12.50%

Revenue / Employee

$141.2K

Net Income / Employee

$-687.7K

Market Cap

$12M

LPCN Employee Count

2011 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-03-10	2025-12-31	14	-2	-12.50%
2025-03-13	2024-12-31	16	-1	-5.88%
2024-03-07	2023-12-31	17	+0	+0.00%
2023-03-10	2022-12-31	17	+4	+30.77%
2022-03-09	2021-12-31	13	+2	+18.18%
2021-03-11	2020-12-31	11	-1	-8.33%
2020-03-13	2019-12-31	12	+2	+20.00%
2019-03-06	2018-12-31	10	-4	-28.57%
2018-03-12	2017-12-31	14	+0	+0.00%
2017-03-06	2016-12-31	14	-6	-30.00%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

ADAP

Adaptimmune Therapeutics plc

Ernexa Therapeutics Inc.

6$2M

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · LPCN peer comparison

About LPCN employees

LPCN Employees · Headcount

Lipocine Inc. (LPCN) employee data is sourced from the annual SEC 10-K filing. As of 2025, Lipocine Inc. had 14 full-time employees globally. Full-time employees only. Global consolidated headcount.

Lipocine Inc. employs 14 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $141,191, reflecting the company's operational efficiency.

Lipocine Inc.'s workforce decreased by 2 (12.50%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Lipocine Inc.'s revenue per employee of $141,191 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

LPCN Employees · 5 questions

As of the latest SEC 10-K filing (2025), Lipocine Inc. had 14 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Lipocine Inc. employee counthow many employees does Lipocine Inc. haveLPCN total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-10